Long-Term Effects of Laparoscopic Roux-en-Y Gastric Bypass on Levothyroxine Dose in Patients with Hypothyroidism
Endocrinology Insights · 2025
DOI: 10.1159/000547586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology Insights, 2025. Verfasst von Patrícia Ferreira und 17 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Bariatric surgery (BS) can affect levothyroxine (LT4) supplementation in patients with hypothyroidism. While post-surgery weight loss may reduce absolute LT4 needs, patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might require higher doses due to impaired gastrointestinal absorption. We aimed to assess the impact of RYGB on LT4 dosage in subjects with hypothyroidism 10 years after intervention. Materials and Methods: This is a retrospective cohort study evaluating adults with obesity and hypothyroidism submitted to RYGB between 2010 and 2013. Preoperative and 10-year postoperative clinical and analytical evaluations were conducted. Simple and multiple linear regressions were performed to assess the impact of preoperative characteristics and weight loss on the variation of absolute and relative (dose per weight) LT4 doses 10 years after RYGB.
Results
Twenty-seven patients were included (96.3% women, mean age 44.3 ± 11.5 years, mean BMI 44.0 ± 5.1 kg/m2). Ten years after RYGB, there was a nonsignificant change in absolute (p = 0.066) or relative (p = 0.091) LT4 doses but a trend toward an increase in relative dosage. Thyroid-stimulating hormone (TSH) levels did not change significantly (p = 0.361). Forty-two percent of patients reduced LT4 needs or discontinued medication while maintaining normal thyroid function. Greater decreases in BMI (β = 0.05 [95% CI: 0.01–0.09]; p = 0.025) and higher percentage of excessive weight loss (β = 0.01 [95% CI: 0.00–0.02]; p = 0.017) were significantly associated with an increase in relative LT4 dose.
Conclusions
Higher weight loss 10 years after RYGB may be associated with an increase in relative LT4 dose but not in absolute dose. However, further studies are necessary to fully understand the impact of RYGB on patients with obesity and hypothyroidism.
Zitieren
APA
Ferreira, P., Leite, A. R., Meira, I., Menino, J., Gonçalves, J., Ferreira, H. U., Ribeiro, S., Moreno, T., Canha, M. B., Silva, M. M., Guerreiro, V., Pedro, J., Varela, A., Silva, D. F., Souto, S. B., Freitas, P., Costa, E. L. D., & Queirós, J. (2025). Long-Term Effects of Laparoscopic Roux-en-Y Gastric Bypass on Levothyroxine Dose in Patients with Hypothyroidism. Endocrinology Insights. https://doi.org/10.1159/000547586
Vancouver
Ferreira P, Leite AR, Meira I, Menino J, Gonçalves J, Ferreira HU, et al. Long-Term Effects of Laparoscopic Roux-en-Y Gastric Bypass on Levothyroxine Dose in Patients with Hypothyroidism. Endocrinology Insights. 2025. doi:10.1159/000547586
BibTeX
@article{Ferreira2025,
author = {Ferreira, Patrícia and Leite, Ana Rita and Meira, Inês and Menino, João and Gonçalves, Juliana and Ferreira, Helena Urbano and Ribeiro, Sara and Moreno, Telma and Canha, Marta Borges and Silva, Maria Manuel and Guerreiro, Vanessa and Pedro, Jorge and Varela, Ana and Silva, Diana Festas and Souto, Selma B. and Freitas, Paula and Costa, Eduardo Lima da and Queirós, Joana},
title = {Long-Term Effects of Laparoscopic Roux-en-Y Gastric Bypass on Levothyroxine Dose in Patients with Hypothyroidism},
journal = {Endocrinology Insights},
year = {2025},
doi = {10.1159/000547586}
}
EUVIMED